MOLT-4 In Vitro High Content Screening (HCS) Assay

This assay is to provide MOLT-4-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

MOLT-4

Human

MOLT-4 is a T lymphoblast cell line derived from the same patient as the MOLT-3 cell line. The line was established from cells taken from a 19-year-old, male patient with Acute lymphoblastic leukemia (ALL) in relapse. This cell line can be used in immunology and immune system disorder research.

Acute Lymphoblastic Leukemia; ALL

Oncology

In Vitro High Content Screening (HCS) Assay

MOLT-4-cell based In Vitro High Content Screening (HCS) Assay

HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.

High-throughput Screening, High Content Screening and Reporter Gene Assays